2024 annual financial data
Marker Therapeutics 2024 Net margin
Direct answer
Net margin was -162.82%.
Operating income was -11,118,372 USD and net income was -10,731,315 USD.
Operating cash flow was -10,910,324 USD.
Get free Marker Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,591,080 USD
- Operating income
- -11,118,372 USD
- Net income
- -10,731,315 USD
- Operating cash flow
- -10,910,324 USD